Patents by Inventor Jittiwud Lertvorachon

Jittiwud Lertvorachon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-GLYCATION AGENTS FOR PREVENTING AGE-, DIABETES-, AND SMOKING-RELATED COMPLICATIONS
    Publication number: 20080139664
    Abstract: The invention provides new inhibitors of protein glycation, identified from compound libraries by a high throughput screening assay. The anti-glycation agents so identified are characterized by a variety of chemical structures and are useful for the prevention or treatment of age-, diabetes-, and smoking-related complications, including neuropathy, nephropathy, ocular pathologies, or the loss of mechanical properties of collagenous tissues. Among compounds identified as having the anti-glycation activity, of special interest are epinephrine and its analogs, in particular D-epinephrine and its analogs, which are particularly useful for the prevention or treatment of age-, diabetes-, and smoking-related ocular pathologies.
    Type: Application
    Filed: February 11, 2008
    Publication date: June 12, 2008
    Applicant: NATIONAL RESEARCH COUNCIL OF CANADA
    Inventors: Faustinus YEBOAH, Yasuo KONISHI, Sung Ju CHO, Jittiwud LERTVORACHON, Taira KIYOTA, Tomasz Popek
  • Anti-glycation agents for preventing age- diabetes- and smoking-related complications
    Publication number: 20050043408
    Abstract: The invention provides new inhibitors of protein glycation, identified from compound libraries by a high throughput screening assay. The anti-glycation agents so identified are characterized by a variety of chemical structures and are useful for the prevention or treatment of age-, diabetes-, and smoking-related complications, including neuropathy, nephropathy, ocular pathologies, or the loss of mechanical properties of collagenous tissues. Among compounds identified as having the anti-glycation activity, of special interest are epinephrine and its analogs, in particular D-epinephrine and its analogs, which are particularly useful for the prevention or treatment of age-, diabetes-, and smoking-related ocular pathologies.
    Type: Application
    Filed: October 15, 2002
    Publication date: February 24, 2005
    Inventors: Faustinus Yeboah, Yasuo Konishi, Sung Cho, Jittiwud Lertvorachon, Taira Kiyota, Popek Tomasz